Data / Form D filings / Perosphere Inc.
Perosphere Inc.: Form D filings
Perosphere Inc., a pharmaceuticals company in Danbury, CT, filed 3 Form D notices with the SEC between 2012 and 2016. The latest, on February 4, 2016, reports $6.2 million sold of a $12 million offering to 42 investors.
Find out what Perosphere Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 20 Kenosia Avenue, Danbury, CT, 06810
- Phone
- (203) 885-1111
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1539923
The full lists. Form D filings in Connecticut: 428 rows, $21.40, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 4, 2016 | Amendment | $12,000,000 | $6,212,355 | $5,787,645 | 42 | Oct 8, 2015 | sec.gov |
| Oct 23, 2015 | New notice | $12,000,000 | $2,123,355 | $9,876,645 | 28 | Oct 8, 2015 | sec.gov |
| Jan 18, 2012 | New notice | $1,500,000 | $1,034,124 | $465,876 | 20 | Dec 16, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Erik E. Steiner | Executive Officer | |
| Solomon S. Steiner | Executive Officer, Director | |
| Peter E. van Straelen | Executive Officer | |
| James C. Costin | Executive Officer | |
| Philip N. Sussman | Executive Officer | |
| Bryan E. Laulicht | Executive Officer | |
| Charles A. Steiner | Director | |
| Andreas S. Pfutzner | Director | |
| Sasha H. Bakhru | Executive Officer |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Feb 1, 2016 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Perosphere Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.